Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort

Published:2015-06-23 Issue:3 Volume:113 Page:382-389
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Cuzick J, ,Stone S,Fisher G,Yang Z H,North B V,Berney D M,Beltran L,Greenberg D,Møller H,Reid J E,Gutin A,Lanchbury J S,Brawer M,Scardino P

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2015223.pdf

Reference26 articles.

1. Albertsen JL, Hanley JA, Gleason DF, Barry MJ (1998) Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280: 975–980.

2. Albertsen PC, Hanley JA, Fine J (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293 (17): 2095–2101.

3. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O’Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD PLCO Project Team (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360 (13): 1310–1319.

4. Bishoff JT, Freedland SJ, Gerber L, Tennstedt P, Reid J, Welbourn W, Graefen M, Sangale Z, Tikishvili E, Park J, Younus A, Gutin A, Lanchbury JS, Sauter G, Brawer M, Stone S, Schlomm T (2014) Prognostic utility of the CCP score generated from biopsy in men treated with prostatectomy. J Urol 192 (2): 409–414.

5. Brawer MK, Cooperberg MR, Freedland SJ, Swanson GP, Stone S, Reid JE, Gutin A, Carroll P, Cuzick JM (2013) Development and validation of a multivariate model combining cell cycle progression score with CAPRA to predict prostate cancer mortality in a conservatively managed cohort. J Clin Oncol 31: 6s (suppl; abstr 67).

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing;Prostate Cancer and Prostatic Diseases;2024-09-05

2. CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer;British Journal of Cancer;2024-08-08

3. Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer;JCO Precision Oncology;2024-05

4. Analysis of the Gene Networks and Pathways Correlated with Tissue Differentiation in Prostate Cancer;International Journal of Molecular Sciences;2024-03-24

5. A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancer;Molecular Medicine;2024-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3